Overview
Resurrect Bio is a UK AgriBioTech startup that develops disease-resistant crop varieties for farmers, seed companies and food producers. The company focuses on agricultural biotechnology approaches to create plant lines that aim to reduce yield losses from pathogens and increase crop resilience across commercial agricultural systems. In May 2026 Resurrect Bio closed a €8.8 million Series A (reported as $10M), its only disclosed financing to date, to advance development and commercialization of its varieties. The firm's key differentiation is its dedicated focus on disease resistance within crop improvement, targeting downstream deployment through seed and farming channels in the agricultural supply chain.
Funding History
UK AgriBioTech startup Resurrect Bio closes €8.8 million Series A to develop disease-resistant crops
Frequently Asked Questions
- How much has Resurrect Bio raised in total?
- Resurrect Bio has raised a total of $10M across 1 funding round.
- Who are Resurrect Bio's investors?
- Resurrect Bio's investors include Undisclosed.
- What does Resurrect Bio do?
- Resurrect Bio is a UK AgriBioTech startup that develops disease-resistant crop varieties for farmers, seed companies and food producers. The company focuses on agricultural biotechnology approaches to create plant lines that aim to reduce yield losses from pathogens and increase crop resilience across commercial agricultural systems. In May 2026 Resurrect Bio closed a €8.8 million Series A (reported as $10M), its only disclosed financing to date, to advance development and commercialization of its varieties. The firm's key differentiation is its dedicated focus on disease resistance within crop improvement, targeting downstream deployment through seed and farming channels in the agricultural supply chain.
- Where is Resurrect Bio headquartered?
- Resurrect Bio is headquartered in United Kingdom.